News & Press Releases
For all media inquiries, please contact us.
Seattle Visit Sparks Effort to Snuff China’s Smoking Habit — With an App
Dr Bricker from Fred Hutch Cancer Research Center visited China to discuss how the SmartQuit app could help smokers quit.
Digital Medicine's March on Chronic Disease
Digital medicine offers the possibility of continuous monitoring, behavior modification and personalized interventions at low cost, potentially easing the burden of chronic disease in cost-constrained healthcare systems.
Smoking Cessation App-Maker Partners with GSK to Offer Nicotine Patches.
Digital smoking cessation company 2Morrow has partnered with GlaxoSmithKline, makers of Nicoderm patches, to offer the company’s Nicoderm CQ Patch to smokers who complete 2morrow’s cessation program.
SmartQuit and GSK Collaborate to Provide NRT to App Users
2Morrow Inc, makers of SmartQuit®, the first clinically proven app to help smokers quit, announced their collaboration with GlaxoSmithKline® to provide nicotine replacement therapy (NRT) to program participants.
China's First Lady Visits Fred Hutch, Talks to Dr. Bricker About Smoking Cessation and SmartQuit
China’s first lady, Peng Liyuan, focused attention on the global-health problems of HIV infection and tobacco use during a hush-hush visit Wednesday to a Seattle cancer center.
Kirkland Smoking Cessation Startup Teams With mHealth Technologies to Help Turkish Smokers Quit
China’s first lady, Peng Liyuan, focused attention on the global-health problems of HIV infection and tobacco use during a hush-hush visit Wednesday to a Seattle cancer center.
North American Quitline Consortium 2015 Conference
Jo Masterson, COO of 2Morrow and Joella Pyatt of WA DOH will be presenting. Using Apps to Help Smokers Quit: Some Research, Data, and Real-world Applications.
SmartQuit App Gets $3.1M From National Cancer Institute for Large Smoking-Cessation Trial
The National Cancer Institute has awarded a $3.1 million, five-year grant to Dr. Jonathan Bricker, a behavioral scientist at Seattle’s Fred Hutchinson Cancer Research Center and the University of Washington, to conduct a large-scale clinical trial for the SmartQuit smoking-cessation app.
Fred Hutch Scientist Gets $3.1M for Stop-Smoking App
A Seattle smoking-cessation researcher has received a $3.1 million, five-year grant from the National Cancer Institute to conduct a gold-standard trial of a promising stop-smoking app. The new trial follows a pilot study of SmartQuit conducted in collaboration with the University of Washington and 2Morrow Mobile.
2Morrow Recruiting for Second Clinical Trial of Smoking Cessation App Program with Employers
A Seattle smoking-cessation researcher has received a $3.1 million, five-year grant from the National Cancer Institute to conduct a gold-standard trial of a promising stop-smoking app. The new trial follows a pilot study of SmartQuit conducted in collaboration with the University of Washington and 2Morrow Mobile.